Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 3, 2022 | OrbiMed | orbimed.com |
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 3, 2026 | HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment | SOMERSET, N.J., March 3, 2026 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a global contract research organization specializing in strategic planning for clinical development and cross‑border clinical trial solutions and... |
| Mar 20, 2025 | HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development | SEOUL, South Korea, March 20, 2025 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing of a Memorandum of Understanding (MOU) with Hallym University Sacred Heart Hospita... |
| Dec 16, 2024 | HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea | SEOUL, South Korea, Dec. 16, 2024 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a boutique global clinical research organization (CRO) providing cross-border clinical trial solutions, proudly announces the signing of a Me... |
| Jul 2, 2024 | HiRO acquires CRO DeltaMed Solutions, continues to expand cross-border operations in the US | WILMINGTON, Del., July 2, 2024 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful acquisition of DeltaMed Solutions, an ... |
| Jul 1, 2024 | HiRO acquires CRO DeltaMed Solutions, continues to expand cross-border operations in the US | WILMINGTON, Del., July 1, 2024 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful acquisition of DeltaMed Solutions, an ... |
| Sep 1, 2023 | HiRO acquires US CRO Courante Oncology, strengthens global footprint and operation capabilities | SINGAPORE, Sept. 1, 2023 /PRNewswire/ -- Harvest Integrated Research Organization (HiRO), an innovation global CRO, is pleased to announce the successful acquisition of Courante Oncology, a US-based full-service clinical research provider s... |
| Sep 1, 2023 | HiRO Acquires Courante Oncology | Harvest Integrated Research Organization (HiRO), a Singapore-based clinical research organization (CRO), acquired Courante Oncology, an Excelsior, MN-based clinical research provider specializing in oncology product development. The amount ... |
| Mar 18, 2022 | Led by OrbiMed, HiRO Raised Tens of Millions of US Dollars in Series A Financing, to Offer Multinational Global Clinical Development Strategy | SHANGHAI, March 18, 2022 /PRNewswire/ -- Harvest Integrated Research Organization ("HiRO" or the "Company") announced the completion of its Series A financing in the tens of millions of US dollars. This round of investme... |
Reviews 0
FAQ about HiRO
Who has invested in HiRO?
Parsers VC lists 2 investors of HiRO, among them OrbiMed.
What has the press written about HiRO?
Parsers VC has collected 9 articles mentioning HiRO, among them “HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment” (Mar 3, 2026) and “HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development” (Mar 20, 2025).
Is HiRO still active?
Yes, HiRO is active; its latest activity on Parsers VC dates from Aug 28, 2026.